Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brett

Showing results (401-410 of 413) with videos related to

Pageof 42
Sort By:
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
The New England Journal of Medicine|November 6, 2014
Clinical presentation of patients with Ebola virus disease in Conakry, GuineaElhadj Ibrahima Bah, Marie-Claire Lamah, Tom Fletcher, et al.
JCI Insight|July 22, 2025
N6-methyladenosine (m6A) dysregulation contributes to network excitability in temporal lobe epilepsyJustine Mathoux, Marc-Michel Wilson, Sujithra Srinivas, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
American Journal of Human Genetics|August 19, 2007
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international studyL Faivre, G Collod-Beroud, B L Loeys, et al.
Cancer Research|July 12, 2020
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP Jake Slavish, Liying Chi, Mi-Kyung Yun, et al.
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Being ready to treat Ebola virus disease patientsDavid M Brett-Major, Shevin T Jacob, Frederique A Jacquerioz, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2020
Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)David M Brett-Major, Elizabeth R Schnaubelt, Hannah M Creager, et al.
Pageof 42

Showing results (401-410 of 413) with videos related to

Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
The New England Journal of Medicine|November 6, 2014
Clinical presentation of patients with Ebola virus disease in Conakry, GuineaElhadj Ibrahima Bah, Marie-Claire Lamah, Tom Fletcher, et al.
JCI Insight|July 22, 2025
N6-methyladenosine (m6A) dysregulation contributes to network excitability in temporal lobe epilepsyJustine Mathoux, Marc-Michel Wilson, Sujithra Srinivas, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
American Journal of Human Genetics|August 19, 2007
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international studyL Faivre, G Collod-Beroud, B L Loeys, et al.
Cancer Research|July 12, 2020
Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP Jake Slavish, Liying Chi, Mi-Kyung Yun, et al.
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Being ready to treat Ebola virus disease patientsDavid M Brett-Major, Shevin T Jacob, Frederique A Jacquerioz, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2020
Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)David M Brett-Major, Elizabeth R Schnaubelt, Hannah M Creager, et al.
Pageof 42